Announced Thu, 18 Jun · 10:58 IST
Ajanta Pharma files FY26 Annual Report; AGM on 16 July 2026
Compliance View source PDF
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.4%1-day move
₹3060.00
prior close
₹3057.60
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.6+0.4+0.4+0.5+0.4+4.2+4.2+6.4+4.3+11.9+10.0+13.3——
Up moveDown movePending
AI summary
Ajanta Pharma submitted its FY26 Annual Report, Business Responsibility and Sustainability Report, and AGM notice. The 47th AGM will be held on 16 July 2026 via video conferencing. FY26 revenue grew 17 percent to Rs 5,453 cr and PAT rose 15 percent to Rs 1,056 cr, both crossing key milestones. US Generics surged 49 percent to Rs 1,557 cr. India Branded Generics grew 14 percent, Africa 15 percent, while Asia fell 1 percent due to Middle East disruptions. Dividend payout of Rs 350 cr.
Likely market impact
Record year with revenue above Rs 5,000 cr and PAT above Rs 1,000 cr. Diversified growth across US, India, and Africa. AGM on 16 July.